We have the instruments. We hired the musicians. So why does pharma marketing still sound like a garage band? This provocative opener unpacks why having an omnichannel strategy is table stakes — and orchestrating it is the real competitive advantage. Expect brutal honesty, live audience polling, and a new framework for 2026 and beyond.
Every pharma company has run an AI pilot. Most of them are gathering dust. This session isolates the pivotal decisions that separate companies still experimenting from those running AI at enterprise scale — covering model governance, content supply, data readiness, change management, and why your biggest blocker isn't technology.
Pharma marketers are sitting on a goldmine of data, but it often lives in silos. This session explores how uniting digital engagement signals with syndicated datasets can unlock a true 360° view of HCP behavior. Learn how leading teams are overcoming integration challenges, ensuring compliance, and transforming raw data into actionable insights that drive precision targeting and smarter engagement strategies.
Hands-on and fast-paced. Attendees bring their laptops and leave with five GenAI content workflows designed specifically for pharma's regulatory environment. Learn how leading brands are using generative AI to cut content cycle times by 40% without sacrificing compliance — and what prompts, guardrails, and review workflows make it possible.
Interactive and collaborative. Attendees work in cross-functional teams to map a patient or HCP journey from awareness to adherence — identifying gaps, prioritizing channels, and defining the metrics that matter. Facilitated by an experienced journey design strategist, this workshop produces a take-home framework every marketer can apply Monday morning.
What if a physician could watch your drug work at the molecular level before they prescribe it? What if a patient could experience their condition — and their treatment — before it happens? This visionary talk showcases the most compelling applications of AR and VR in pharma marketing and medical education, and makes the case for early adoption.
Launch failures are rarely about the science. They're about the strategy, the timing, and the execution. This high-energy panel brings together three commercial launch leaders to share what separates successful launches from expensive disappointments — covering HCP targeting, patient activation, payer access, and the role of AI in launch readiness.
The old model: reach more people, more often. The new model: reach the right people, at the right moment, with the right message, on the right channel. This talk dismantles the volume-first mindset that's been costing pharma brands millions in wasted spend — and introduces the precision engagement framework that's replacing it.
The agency model is under pressure. Clients want more speed, more data fluency, more regulatory knowledge, and more creative courage — often for less. This frank panel, featuring both brand-side and agency-side leaders, explores what great partnership looks like in 2026, and what both sides need to change to get there.
A candid, forward-looking conversation between two industry visionaries about what's coming next — from AI agents that manage entire HCP relationships autonomously, to regulatory frameworks that haven't been written yet. Equal parts inspiring and sobering. Includes live Q&A from the audience.
